A California appeals court has reinstated the eligibility of thousands of cases against Johnson & Johnson and its Janssen Pharmaceuticals subsidiary, alleging that the company’s antipsychotic drug Risperdal causes abnormal breast growth in males. The court ruling reverses a lower court’s decision to grant Johnson & Johnson’s motion for summary judgment on the grounds that […]